ConductScience.org, home

Gene · 2176

Papers2,586

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

901 to 920 of 2,586

Download this page as JSON
TitleJournalYearPMIDFound bySource
Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates.Sci Rep202133753785PubTator, text miningPubMed
Sedimentary evolution and controlling factors of Early-Mid Miocene Deltaic systems in the Northern Pearl River Mouth Basin, South China Sea.Sci Rep202133731758PubTator, text miningPubMed
Evaluating the role of GSTP1 genetic polymorphism (rs1695, 313A>G) as a predictor in cyclophosphamide-induced toxicities.Medicine (Baltimore)202133725933PubTator, text miningPubMed
Beyond DNA repair and chromosome instability-Fanconi anaemia as a cellular senescence-associated syndrome.Cell Death Differ202133723374PubTator, text miningPubMed
Mechanisms of damage tolerance and repair during DNA replication.Nucleic Acids Res202133693881PubTator, text miningPubMed
Structure of the FA core ubiquitin ligase closing the ID clamp on DNA.Nat Struct Mol Biol202133686268PubTator, text miningPubMed
FANCA Gene Mutations in North African Fanconi Anemia Patients.Front Genet202133679882PubTator, text miningPubMed
DNA methylation mediates the effect of maternal smoking on offspring birthweight: a birth cohort study of multi-ethnic US mother-newborn pairs.Clin Epigenetics202133663600PubTator, text miningPubMed
Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps.J Enzyme Inhib Med Chem202133663315PubTator, text miningPubMed
Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing.
Breast Cancer Res Treat202133649982PubTator, text miningPubMed
Benefits of Iron Chelators in the Treatment of Parkinson's Disease.Neurochem Res202133646533PubTator, text miningPubMed
Perspectives on PARP inhibitors as pharmacotherapeutic strategies for breast cancer.Expert Opin Pharmacother202133646064PubTator, text miningPubMed
In Gratitude!CASE (Phila)202133644504PubTator, text miningPubMed
Area Available for Atrial Fibrillation to Propagate Is an Important Determinant of Recurrence After Ablation.JACC Clin Electrophysiol202133640348PubTator, text miningPubMed
Pancreatic ductal adenocarcinoma in the era of precision medicine.Semin Oncol202133637355PubTator, text miningPubMed
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer.J Pathol Clin Res202133630412PubTator, text miningPubMed
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.JAMA Oncol202133630025PubTator, text miningPubMed
Comprehensive analysis of macrophage-related multigene signature in the tumor microenvironment of head and neck squamous cancer.Aging (Albany NY)202133592580PubTator, text miningPubMed
The involvement of marine tourism companies in CSR: the case of the island of Tenerife.Environ Dev Sustain202133584128PubTator, text miningPubMed
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.Clin Lung Cancer202133583720PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2176/papers?page=46